Table 10.

Change in Z-Scores from Baseline to End-Point

	Mean±SD	Mean±SD
Height Z-score, cm	Placebo n=44	Escitalopram n=52	p Valuea
Baseline of lead-in study	0.59±1.07	0.22±1.19
End-point	0.74±0.98	0.32±1.22
Change	0.16±0.36	0.10±0.24	0.210

Weight Z-score, kg	Placebo n=77	Escitalopram n=80
Baseline of lead-in study	1.38±1.16	1.06±1.20
End-point	1.45±1.13	1.15±1.19
Change	0.08±0.15	0.09±0.21	0.944

Body mass index Z-score, kg/m2	Placebo n=44	Escitalopram n=52
Baseline of lead-in study	1.30±1.26	0.96±1.19
End-point	1.32±1.12	1.01±1.20
Change	0.03±0.37	0.05±0.22	0.999

^aAnalysis of covariance (ANCOVA) analysis with baseline values as a covariate.